These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9159748)

  • 1. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?
    Lamberti P; de Mari M; Iliceto G; Federico F
    Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H; Mizuno Y
    No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report.
    Kikuchi A; Takeda A; Fujihara K; Kimpara T; Shiga Y; Tanji H; Nagai M; Ichinose H; Urano F; Okamura N; Arai H; Itoyama Y
    Mov Disord; 2004 May; 19(5):590-3. PubMed ID: 15133828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopamine agonists in the therapy of parkinson syndrome].
    Kapfhammer HP; Rüther E
    Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

  • 9. Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: case report.
    Gambarin M; Antonini A; Moretto G; Bovi P; Romito S; Fiaschi A; Tinazzi M
    Mov Disord; 2006 Feb; 21(2):270-3. PubMed ID: 16161148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD; Ismail HA; Frank C
    Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia.
    Margari L; de Mari M; Lamberti P; Iliceto G; Serlenga L; Perniola T; Rossini PM; Ferrari E
    Funct Neurol; 1995; 10(2):99-105. PubMed ID: 7557558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopa-therapy in the treatment of early stage Parkinson's disease].
    Broussolle E
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():91-7. PubMed ID: 10916042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa: the story so far.
    Abbott A
    Nature; 2010 Aug; 466(7310):S6-7. PubMed ID: 20739934
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinsonism: candidate disorder for implanted pumps?
    Nutt JG
    Ann N Y Acad Sci; 1988; 531():194-9. PubMed ID: 2898229
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
    Garraux G; Caberg JH; Vanbellinghen JF; Jamar M; Bours V; Moonen G; Dive D
    Arch Neurol; 2012 Mar; 69(3):398-400. PubMed ID: 22410449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REAL and CALM: what have we learned?
    Morrish PK
    Mov Disord; 2003 Jul; 18(7):839-40. PubMed ID: 12815670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.